Seek symptom relief
For some patients, injection may be considered to reduce discomfort. Responses vary, and average benefits observed in studies are limited.
SPORTS ORTHOPEDICS • KNEE TREATMENT
Injections are one of the options that may be discussed in selected cases of knee pain, including osteoarthritis and some situations involving chondromalacia. The first step is understanding the cause of your symptoms and whether this procedure makes sense for you.
INDIVIDUALIZED ASSESSMENT
Pain while walking, climbing stairs, squatting or playing sports can have different causes. Hyaluronic acid injection may be considered in certain situations, but is not appropriate for everyone. Physical examination, symptoms, activity level and goals help determine the best approach.
Therapeutic exercise, strengthening, load management and other conservative measures remain pillars of osteoarthritis and patellofemoral pain treatment. In most cases, care begins with physical therapy. In selected situations, injection may be considered earlier after discussing uncertainties, risks and alternatives; this does not mean early injection has demonstrated superior effectiveness.
POSSIBLE TREATMENT GOALS
For some patients, injection may be considered to reduce discomfort. Responses vary, and average benefits observed in studies are limited.
Walking, climbing stairs and exercising are important goals. The plan combines options appropriate to the diagnosis and functional capacity.
Assessment, strengthening and follow-up are part of caring for the knee whether or not an injection is performed.
Dr. Thiago Righetto · Sports orthopedics, arthroscopy and knee surgery. Indications are determined during consultation following clinical assessment and discussion of alternatives.
MECHANISM OF ACTION
Hyaluronic acid is a natural component of synovial fluid. Its viscoelastic properties contribute to lubrication and the joint's mechanical response.
Experimental studies describe interactions with cell receptors, including CD44, and potential effects on inflammatory and nociceptive pathways. These mechanisms do not guarantee meaningful clinical benefit in humans.
When considered, the clinical goal is to attempt to reduce symptoms and improve function. It should not be described as cartilage reconstruction or a cure for osteoarthritis.
Mechanistic background: Nature Reviews Rheumatology (2025) and American Journal of Sports Medicine (2025). Biological mechanisms and clinical efficacy are different questions.
ANTERIOR KNEE PAIN
Chondromalacia describes changes in the cartilage of the kneecap. Patellofemoral pain syndrome is a clinical diagnosis often associated with pain during squatting, climbing or descending stairs, running or sitting for long periods. These conditions can coexist but are not synonyms, nor do they necessarily mean patellofemoral osteoarthritis.
In most cases, initial treatment includes physical therapy, progressive quadriceps and hip strengthening, education and load management. Depending on symptoms, functional limitations and clinical context, injection may be discussed at different stages, including earlier in selected situations, with realistic expectations.
Even if an injection is chosen, symptoms, function and load tolerance must be reassessed, and rehabilitation organized. Follow-up helps adapt the plan to recovery and address contributing factors.
BENEFITS AND LIMITATIONS
Some patients report less pain and greater comfort during activities, but responses vary. For knee osteoarthritis, a major systematic review in the BMJ in 2022, including 169 clinical trials, found a small average benefit compared with placebo — approximately 2 points on a 0–100 pain scale in large controlled trials.
It is therefore important to decide whether the procedure suits your symptoms and goals without neglecting strengthening and other treatments.
Guidelines such as those of the American College of Rheumatology/Arthritis Foundation do not recommend routine hyaluronic acid injections for osteoarthritis. In certain situations, the option can be discussed after considering other treatments, patient preferences and evidence limitations.
SAFETY
Discomfort, tenderness or some knee swelling may occur and are generally temporary. You receive advice on care and activities after the procedure.
Joint infection after an injection is rare but requires prompt care if suspected. More pronounced inflammatory reactions can also occur. Aseptic technique and appropriate assessment are essential safety measures.
A major BMJ review found a relative increase in serious adverse events in osteoarthritis viscosupplementation trials (RR 1.49). This does not mean severe complications are common or that all events were caused by the injection. Risks and benefits are discussed individually before deciding.
ABOUT THE PRODUCT USED
In my practice I use KD Intra-articular Gel Ultra One, a hyaluronic acid preparation for intra-articular use. Technical specifications, contraindications and application precautions should be checked against the manufacturer's current instructions for use.
Product selection is part of procedural planning. Studies on hyaluronic acid generally do not establish that KD Ultra One provides superior results to other formulations, so indication and follow-up remain essential.
Device technical information: KD Intra-articular Gel One/Ultra One instructions for use, Brazilian Anvisa registration 81666770006. This document identifies the product and is not presented as clinical evidence of efficacy.
AFTER INJECTION
An injection is only one possible step. Follow-up allows symptom assessment, rehabilitation adjustments and guidance for returning to activities with confidence.
Monitor pain, joint effusion, load tolerance and reactions after the procedure.
Individualize strengthening, mobility, conditioning and activity progression according to diagnosis and clinical response.
Track the ability to walk, climb stairs, train and resume meaningful activities.
Follow-up is part of comprehensive knee care, although no specific protocol has been proven to increase hyaluronic acid's effect.
FREQUENTLY ASKED QUESTIONS
There is no robust clinical evidence that hyaluronic acid injections regenerate cartilage or reverse osteoarthritis. Their use has mainly been studied for symptom relief, with different evidence depending on the diagnosis.
Not necessarily. When improvement occurs, it may develop over several weeks. Response varies and cannot be guaranteed.
They are not an established effective treatment for patellofemoral pain or chondromalacia. In selected cases, they may be discussed individually, explaining the limited evidence while keeping rehabilitation central.
In most cases, physical therapy and strengthening are first-line treatment. In selected situations an injection may be considered earlier, but robust evidence does not establish superiority of that strategy for patellofemoral pain.
No. Major guidelines do not recommend routine use. When considered, the decision depends on symptoms, previous treatments, risks, preferences and shared decision-making.
Return should follow symptoms, individualized advice and progressive loading. Injections do not replace strengthening and rehabilitation.
SCIENTIFIC REFERENCES
Clinical content grounded in peer-reviewed literature, prioritizing systematic reviews and high-impact studies. Product technical information is identified separately.
The AAOS knee osteoarthritis guideline also does not recommend viscosupplementation as routine treatment.
During consultation, we assess the cause of pain, previous treatments and options for your case. If an injection is considered, it will be part of a follow-up and rehabilitation plan.
Dr. Thiago Righetto · CRM/SP 125722 · RQE 40299